According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032.
Checkpoint inhibitor refractory cancer occurs when tumors develop...
Executive Summary RNA-Based Cancer Therapeutics Market Size and Share Across Top Segments
CAGR Value
The global RNA-based cancer therapeutics market size was valued at USD 415.8 million in 2025 and is expected to reach USD 947.1 million by 2033, at a CAGR of 10.80% during the forecast period
Market drivers and market restraints covered in this...
The Oncology Small Molecule Drugs Market is evolving rapidly as pharmaceutical innovators and healthcare systems worldwide intensify efforts against cancer with advanced therapeutics and strategic investments. According to the latest Oncology Small Molecule Drugs Market report by The Insight Partners, this market is poised to grow at a compound annual growth rate (CAGR) of 5.6% from 2025 to...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek